Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Kolavennu: Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy.... (0.10 sec) 

Targeting of RhoA/ROCK signaling ameliorates progression of diabetic …

- diabetesjournals.org
V Kolavennu, L Zeng, H Peng, Y Wang, FR Danesh - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—RhoA, a small GTPase protein, and its immediate downstream target, Rho kinase
(ROCK), control a wide variety of signal transduction pathways. Recent studies have shown that
fasudil, a selective ROCK inhibitor, may play a pivotal role in a number of pathological ...
Cited by 17 - Related articles - BL Direct - All 4 versions

A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy …

- endocrinology-journals.org
Y Kikuchi, M Yamada, T Imakiire, T … - Journal of …, 2007 - Soc Endocrinology
Fasudil, a Rho-kinase inhibitor, may improve insulin signaling. However, its long-term effect on
metabolic abnormalities and its preventive effect on diabetic nephropathy are still unknown. We
assessed these effects of fasudil in insulin-resistant diabetic rats, comparing them with ...
Cited by 16 - Related articles - BL Direct - All 4 versions

RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease


F Peng, D Wu, B Gao, AJ Ingram, B Zhang, K … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Glucose led to RhoA and downstream Rho-kinase activation. Mannitol was without
effect. Activity of the transcription factor AP-1, increased in diabetic MCs and kidneys, is important
in the profibrotic effects of glucose, and this was dependent on Rho-kinase signaling. ...
Cited by 10 - Related articles - All 4 versions

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin …


A Gojo, K Utsunomiya, K Taniguchi, T Yokota, S … - European journal of …, 2007 - Elsevier
This study aimed to investigate the effect of the Rho-kinase inhibitor fasudil on the development
of diabetic nephropathy and clarify a contribution of the Rho/Rho-kinase pathway to the pathogenesis
of diabetic nephropathy. Diabetes was induced in male Sprague–Dawley rats with an ...
Cited by 22 - Related articles - All 4 versions

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

- oxfordjournals.org
HL Heerspink, T Greene, JB Lewis, I Raz, RD … - Nephrology Dialysis …, 2008 - ERA-EDTA
Methods. A total of 149 patients with type 2 diabetes and an albumin:creatinine ratio (ACR) between
20 and 300 mg/g were randomized with equal allocation to either placebo, 200 mg of sulodexide
or 400 mg of sulodexide. The primary endpoint was the achievement, at 6 months, of ...
Cited by 11 - Related articles - BL Direct - All 4 versions

High glucose increases phosphocofilin via phosphorylation of LIM kinase due to …


F Ishibashi - Diabetes research and clinical practice, 2008 - Elsevier
In proximal tubular epithelial cells (PTECs), depolymerization of actin by cofilin plays a crucial
role in maintaining polarity and function. Cofilin is inactivated when phosphorylated by
p-Lin-11/Isl-1/Mec-3 kinase (LIMK) to give p-cofilin. LIMK is phosphorylated by ...
Cited by 2 - Related articles - All 7 versions

Rho kinase inhibition: a new approach for treating diabetic nephropathy?

- diabetesjournals.org
LA Bach - Diabetes, 2008 - Am Diabetes Assoc
RhoA/ROCK has a number of functions in the kidney. RhoA/ROCK enhances Ca 2+ -dependent
vascular smooth muscle contraction, thereby modulating tone (2–4). The potent vasoconstrictor
angiotensin II (AngII) activates ROCK in smooth muscle cells. The ROCK inhibitors fasudil ...
Cited by 2 - Related articles - BL Direct - All 3 versions

The effects of spironolactone on nephron function in patients with diabetic …


A Ustundag, A Tugrul, S Ustundag, N Sut, B … - Renal …, 2008 - informahealthcare.com
Increasing evidence suggests that circulating aldosterone per se contributes directly to renal
and cardiovascular diseases. We sought to evaluate the effects of a three-month treatment with
25 mg spironolactone, an aldosterone receptor antagonist, on nephron function in 20 type ...
Cited by 2 - Related articles - All 5 versions

High glucose induces plasminogen activator inhibitor-1 expression through Rho/ …


H Iwasaki, R Okamoto, S Kato, K Konishi, H Mizutani, N … - Atherosclerosis, 2008 - Elsevier
PAI-1 expression in BAEC was significantly increased in accordance with the concentration of
glucose in media from 5.7 mM to 23 mM. Stimulation with high glucose (23 mM) significantly
increased small GTPase RhoA activation. Pretreatment with a Rho-kinase inhibitor, ...
Cited by 12 - Related articles - All 18 versions

Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in …


MT Coughlan, JM Forbes, ME Cooper - Kidney International, 2007 - nature.com
The biochemical process of advanced glycation appears to play a central role in the development
and progression of diabetic vascular complications. A number of strategies to influence this pathway
have been designed, one of which involves the putative advanced glycation end-product ( ...
Cited by 13 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google